DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy.
Heo H, Kim JH, Lim HJ, Kim JH, Kim M, Koh J, Im JY, Kim BK, Won M, Park JH, Shin YJ, Yun MR, Cho BC, Kim YS, Kim SY, Kim M.
Heo H, et al. Among authors: kim sy, kim m, kim bk, kim ys, kim jh.
Exp Mol Med. 2022 Aug;54(8):1236-1249. doi: 10.1038/s12276-022-00836-7. Epub 2022 Aug 23.
Exp Mol Med. 2022.
PMID: 35999456
Free PMC article.